FOR Dar es Salaam resident Frank Latamani, the chronic skin condition known as Psoriasis has become not only a painful ordeal ...

The global psoriasis burden shows a slight increase from 1990 to 2021 and is projected to rise further by 2050.

Newly identified bones tie the mysterious Burtele foot to a new Australopithecus species that lived alongside Lucy more than ...

In older adults with psoriasis or psoriatic arthritis, use of two biologic classes was associated with lowest rates of serious adverse events than time off those drugs.

Psoriasis can affect the fingers, knuckles, nails, palms, and soles. Here’s what this psoriasis looks like and how to relieve symptoms like itch.

New 48-week data from the Phase IIIb APEX trial (NCT04882098) show Tremfya (guselkumab; Johnson & Johnson) produces sustained inhibition of radiographic progression and improved clinical symptoms in ...

Treatment with envudeucitinib was safe and effective through 52 weeks among patients with with moderate to severe plaque psoriasis.

Arcutis Canada, Inc., a commercial-stage company focused on delivering meaningful innovations in immuno-dermatology, is pleased to announce that Health Canada has approved PrZORYVE® (roflumilast foam ...

Psoriatic arthritis, a chronic autoimmune condition, links psoriasis with joint inflammation, affecting skin, nails, eyes, and even internal organs. E ...

Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628, for the Phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers (DFU) patients ...

LOS ANGELES (KABC) -- When you jump in the shower, it's fair to say not every body part gets an equal amount of cleaning. Your feet can be easy to overlook, but experts say that feet are just as - if ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...